DK0873405T3 - Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer - Google Patents

Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer

Info

Publication number
DK0873405T3
DK0873405T3 DK97902909T DK97902909T DK0873405T3 DK 0873405 T3 DK0873405 T3 DK 0873405T3 DK 97902909 T DK97902909 T DK 97902909T DK 97902909 T DK97902909 T DK 97902909T DK 0873405 T3 DK0873405 T3 DK 0873405T3
Authority
DK
Denmark
Prior art keywords
ease
expression
sequence elements
enhancing sequence
eukaryotic
Prior art date
Application number
DK97902909T
Other languages
Danish (da)
English (en)
Inventor
Arvia E Morris
Chi-Chang Lee
James N Thomas
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DK0873405T3 publication Critical patent/DK0873405T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Amplifiers (AREA)
  • Error Detection And Correction (AREA)
DK97902909T 1996-01-11 1997-01-10 Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer DK0873405T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58650996A 1996-01-11 1996-01-11
EP97902909A EP0873405B1 (de) 1996-01-11 1997-01-10 Expressionssteigernde sequenzelemente (ease) für eukaryontische expressionssysteme

Publications (1)

Publication Number Publication Date
DK0873405T3 true DK0873405T3 (da) 2005-01-17

Family

ID=24346030

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902909T DK0873405T3 (da) 1996-01-11 1997-01-10 Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer

Country Status (14)

Country Link
US (3) US6027915A (de)
EP (1) EP0873405B1 (de)
JP (1) JP3495375B2 (de)
KR (1) KR19990077015A (de)
AT (1) ATE275628T1 (de)
AU (1) AU708981B2 (de)
CA (1) CA2241174C (de)
DE (1) DE69730592T2 (de)
DK (1) DK0873405T3 (de)
ES (1) ES2227669T3 (de)
NO (1) NO323277B1 (de)
NZ (1) NZ330926A (de)
PT (1) PT873405E (de)
WO (1) WO1997025420A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT873405E (pt) * 1996-01-11 2005-01-31 Immunex Corp Elementos de sequencia que aumentam a expressao (ease) para sistemas de expressao eucarioticos
US6596514B2 (en) * 1996-01-11 2003-07-22 Immunex Corporation Expression augmenting sequence elements (EASE) for eukaryotic expression systems
EP0951551B9 (de) 1996-12-23 2012-12-26 Immunex Corporation Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
EP1222298B1 (de) * 1999-10-13 2005-12-07 Immunex Corporation Vektoren und verfahren für rekombinante proteinexpression
JP2003535037A (ja) 1999-12-23 2003-11-25 ザイモジェネティクス，インコーポレイティド 炎症を治療する方法
KR100450266B1 (ko) * 2002-01-16 2004-09-30 주식회사 엘지생명과학 유전자 발현 동물세포 제조용 바이시스트로닉 벡터 및이를 포함하는 세포주 그리고 이를 이용한 항체단백질의생산방법
AU2003228383A1 (en) * 2002-04-09 2003-10-27 Global Biotech Inc. Human tissue urokinase type plasminogen activator production
WO2004007664A2 (en) * 2002-05-28 2004-01-22 Maxygen, Inc. Nucleic acid vectors
JP2005031812A (ja) * 2003-07-08 2005-02-03 Toshiba Corp 画像形成装置およびその制御方法
KR100807312B1 (ko) 2005-10-22 2008-02-28 (주)리즈바이오텍 재조합 인간 인슐린 유사 성장 인자 결합 단백질-3의 생산정제 방법
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
EP2500416A1 (de) 2006-09-13 2012-09-19 Abbott Laboratories Verbesserungen an Zellkulturen
MY161866A (en) 2006-09-13 2017-05-15 Abbvie Inc Cell culture improvements
SG182953A1 (en) 2007-03-30 2012-08-30 Abbott Lab Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
US8815794B2 (en) 2008-08-28 2014-08-26 The Research Foundation For The State University Of New York Treatment of amyloidoses using myelin basic protein and fragments thereof
JP4568378B2 (ja) * 2008-08-29 2010-10-27 東洋紡績株式会社 遺伝子発現安定化エレメント
US20100183620A1 (en) 2008-11-26 2010-07-22 Kaumudi Bhawe Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
US9284563B2 (en) 2009-06-15 2016-03-15 Cellagenics B.V. Stringent selectable markers
CN103038352B (zh) * 2010-06-15 2015-12-16 萨拉基尼克有限公司 用于增强基因表达的新型基因间元件
KR101599138B1 (ko) * 2014-06-17 2016-03-03 한국생명공학연구원 재조합 단백질 발현 증진을 위한 유전자 절편을 포함하는 벡터 및 이의 용도
WO2016003368A1 (en) * 2014-07-01 2016-01-07 Agency For Science, Technology And Research Optimized vectors for the production of recombinant proteins
WO2020068631A1 (en) * 2018-09-24 2020-04-02 Merck Sharp & Dohme Corp. Expression vectors for eukaryotic expression systems
CN113195712A (zh) 2018-12-10 2021-07-30 美国安进公司 突变型piggyBac转座酶
WO2020132382A1 (en) 2018-12-21 2020-06-25 Merck Sharp & Dohme Corp. Expression vectors for eukaryotic expression systems
BR112021024665A2 (pt) * 2019-06-07 2022-02-08 Biocon Biologics Ltd Vetores de expressão em mamíferos
TW202233660A (zh) 2020-10-30 2022-09-01 美商安進公司 過表現胰島素樣生長因子受體突變體以調節ｉｇｆ補充
WO2022140389A1 (en) 2020-12-22 2022-06-30 Amgen Inc. Cell culture method
EP4351722A1 (de) 2021-06-10 2024-04-17 Amgen Inc. Manipulierte nrg-1-varianten mit verbesserter selektivität gegenüber erbb4 aber nicht gegen erbb3
TW202328442A (zh) 2021-09-10 2023-07-16 美商安進公司 平臺宿主對ｉｇｆ—培養基之適應

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3730246A1 (de) * 1987-09-09 1989-06-01 Boehringer Mannheim Gmbh Expressionsvektor und verfahren zur expression von heterologen proteinen in saeugerzellen
PT873405E (pt) * 1996-01-11 2005-01-31 Immunex Corp Elementos de sequencia que aumentam a expressao (ease) para sistemas de expressao eucarioticos

Also Published As

Publication number Publication date
CA2241174C (en) 2006-09-12
AU1697397A (en) 1997-08-01
US6309841B1 (en) 2001-10-30
KR19990077015A (ko) 1999-10-25
WO1997025420A1 (en) 1997-07-17
DE69730592D1 (de) 2004-10-14
EP0873405A4 (de) 2001-10-17
ATE275628T1 (de) 2004-09-15
AU708981B2 (en) 1999-08-19
NZ330926A (en) 1999-11-29
EP0873405B1 (de) 2004-09-08
JP2000503205A (ja) 2000-03-21
US6312951B1 (en) 2001-11-06
ES2227669T3 (es) 2005-04-01
US6027915A (en) 2000-02-22
CA2241174A1 (en) 1997-07-17
PT873405E (pt) 2005-01-31
NO983102D0 (no) 1998-07-03
JP3495375B2 (ja) 2004-02-09
NO323277B1 (no) 2007-02-26
NO983102L (no) 1998-09-08
EP0873405A1 (de) 1998-10-28
DE69730592T2 (de) 2005-09-29

Similar Documents

Publication Publication Date Title
DK0873405T3 (da) Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer
DK1395669T3 (da) Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
SV1997000018A (es) Proteinas inhibisoras (bikunin humano)
HUP9700428A2 (hu) Célsejtspecifikus vektorok gének beépítésére, a vektorokat tartalmazó gyógyászati készítmények és azok alkalmazása
BR0214350A (pt) Sequências de ácido nucleico e aminoácido de adenovìrus de sìmio, vetores contendo as mesmas e métodos de uso
ATE500323T1 (de) Subtilisin-variante
HUP0001650A2 (hu) Javított expressziós vektorok
AU2002257420A1 (en) A system for inducible expression in eukaryotic cells
ATE440611T1 (de) Virale vektoren
WO2002086144A3 (en) Compositions and methods for recombinational cloning of nucleic acid molecules
WO2002006457A3 (en) Novel lipase genes
IL148785A0 (en) Vectors and methods for recombinant protein expression
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
FI962268A0 (fi) Homologinen, rekombinanttinen vasta-aineilmentämisjärjestelmä rottien tai hiirien soluille
DE69535696D1 (de) Tripeptidyl-aminopeptidase
NO20000097D0 (no) Isolerte dendrittcellemembranproteingener
DK1025245T3 (da) Hurtig etablering af stabile pattedyrscelelinjer, der producerer höje koncentrationer af rekombinante proteiner
WO2001025438A3 (en) Ifn-alpha homologues
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
AU5776799A (en) Modified hcv peptide vaccines
ATE288488T1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
FI951633A0 (fi) Erittyvien proteiinien lisääntynyt tuotanto eukaryoottisilla yhdistelmäsoluilla
ATE321842T1 (de) Extrazelluläre serinprotease
WO2001014519A3 (en) Methods and compositions for regulating developmental identity